Thymidylate Kinase Inhibitor, YMU1
CAS No. 902589-96-2
Thymidylate Kinase Inhibitor, YMU1 ( —— )
产品货号. M24937 CAS No. 902589-96-2
YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥583 | 有现货 |
|
10MG | ¥915 | 有现货 |
|
25MG | ¥1847 | 有现货 |
|
50MG | ¥2973 | 有现货 |
|
100MG | ¥4787 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Thymidylate Kinase Inhibitor, YMU1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
-
产品描述YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体hTMPK
-
研究领域——
-
适应症——
化学信息
-
CAS Number902589-96-2
-
分子量378.5
-
分子式C17H22N4O4S
-
纯度>98% (HPLC)
-
溶解度DMSO:10 mM
-
SMILESCCOC(=O)N1CCN(CC1)C(=O)CN2C(=O)C3=C(S2)N=C(C=C3C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Dong B , Jaeger A M , Hughes P F , et al. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1[J]. Science Translational Medicine, 2020, 12(574):eabb5647.
产品手册
关联产品
-
Microgrewiapine A
Microgrewiapine A is a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes.
-
Exendin-4 peptide de...
FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS is an Exendin-4 peptide derivative.Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may relates to dual GLP-1/glucagon receptor agonists.
-
edetate calcium diso...
Edetate calcium disodium, a chelating agent, is primarily used for the management of severe lead poisoning.